ArticleScientific reports2026
Postnatal development outcomes in mice after gestational exposure to polystyrene nanoplastics.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Nanoplastics (< 1 μm) are contaminants of emerging concern. Humans are daily exposed to these particles, and they have even been found in placental tissue, raising concern regarding gestational exposure. Thus, the present work aimed to investigate the effects of gestational exposure to polystyrene nanoplastics (PS-NP) and postnatal development outcomes. Female C57BL/6 mice (n = 9) where mated with male BALB/c mice (n = 9). Dams were separated into two experimental groups: PS-NP (n = 4), which was treated by gavage with 0.15 mg/d (7.5 mg/kg/d) of PS-NP (500 nm) diluted in distilled water (vehicle), and Control (n = 5), which was treated by gavage with distilled water between gestational days 5 and 19. The offspring were evaluated for developmental milestones between postnatal days (PND) 1 and 21. Males were euthanized on PND 42 and 70 to assess organ weights, testes and epididymides development, and sperm quality. In the PS-NP group, females had increased anogenital distance (AGD), while males showed a tendency toward reduced AGD and delayed cliff-avoidance reflex. On PND 42, males had significantly lower brain and kidney weights. Considering the small sample size, these preliminary findings highlight that even low doses of PS-NP during pregnancy may affect early development, raising concerns regarding human health and fertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.